Mark De Souza

Dr. de Souza has deep experience in creating and developing virtual biotechnology companies. He has participated as a CEO/Executive Chairman/Co-Founder of NFlection Therapeutics, Chromaderm, SeylanMed, PellePharm, MyoTherix, Lotus Tissue Repair, and others. Mark has spent 15+ years in the rare disease, neurology, and dermatology spaces.